Bafna Pharmaceuticals profit increases 87.89% in (Q3) FY 2020-21

Source

Team Infinities:

Bafna Pharmaceuticals Limited NSE Symbol:BAFNAPH, BSE Security Code:532989 has declared its 3rd(third) quarter unaudited standalone financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
175.14 154.27 100.58 498.19 302.66
Calculated Revenue of Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
20.87 13.53%(Revenue Increase) 74.56 74.13%(Revenue Increase) 195.53 64.60%(Revenue Increase)

Revenue: Bafna Pharmaceuticals Limited's financial report shows that the company's revenue increased by 13.53% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.20.87 millions, as the company posted revenue of Rs.175.14 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.154.27 millions.
The result also shows that the company's revenue increased by 74.13% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.74.56 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.100.58 millions.
The company also reported that its revenue increased by 64.60% in 9 months end(April, 2020 - December, 2020) for revenue increase of Rs.195.53 millions, since the company reported revenue of Rs.498.19 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.302.66 millions.

Gross Margin(%) Reported by Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
93.65 27.88 17.68 35.41 13.53
Calculated Gross Margin(%) of Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
65.77 235.93%(GM Increase) 75.97 429.67%(GM Increase) 21.88 161.67%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 235.93% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 65.77% GM increase, as the company reported 93.65% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 27.88% GM.
The result also indicates, the company's GM increased by 429.67% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 75.97% GM increase; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 17.68% GM.
The company also reported that its GM increased by 161.67% in 9 months end(April, 2020 - December, 2020) for 21.88% GM increase, since the company reported 35.41% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 13.53% GM.

EBITDA Reported by Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
22.48 15.14 214.64(Negative) 65.38 238.12(Negative)
Calculated EBITDA of Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
7.34 48.48%(EBITDA Increase) 237.12 110.47%(EBITDA Increase) 303.50 127.46%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 48.48% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.7.34 millions, as the company posted EBITDA of Rs.22.48 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.15.14 millions.
The result also shows that the company's EBITDA increased by 110.47% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.237.12 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted Negative EBITDA of Rs.214.64 millions.
The company also reported that its EBITDA increased by 127.46% in 9 months end(April, 2020 - December, 2020) for EBITDA increase of Rs.303.50 millions, since the company reported EBITDA of Rs.65.38 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted Negative EBITDA of Rs.238.12 millions.

Profit and Loss Reported by Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
9.00(Profit ) 4.79(Profit ) 223.29(Loss ) 31.91(Profit ) 250.47(Loss )
Calculated Profit and Loss of Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
4.21 87.89%(Profit Increase) 232.29 104.03%(Profit Increase) 282.38 112.74%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 87.89% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit increase of Rs.4.21 millions, as the company posted profit of Rs.9.00 millions; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.4.79 millions.
The result also shows that the company's profit increased by 104.03% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.232.29 millions; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted loss of Rs.223.29 millions.
The company also reported that its profit increased by 112.74% in 9 months end(April, 2020 - December, 2020) for profit increase of Rs.282.38 millions, since the company reported profit of Rs.31.91 millions; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted loss of Rs.250.47 millions.

EPS Reported by Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
0.38 0.20 0.25(Negative) 1.35 105.88(Negative)
Calculated EPS of Bafna Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.18 90.00%(EPS Increase) 0.63 252.00%(EPS Increase) 107.23 101.28%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 90.00% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.18, as the company posted EPS of Rs.0.38; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.0.20.
The result also shows that the company's EPS increased by 252.00% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.63; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted Negative EPS of Rs.0.25.
The company also reported that its EPS increased by 101.28% in 9 months end(April, 2020 - December, 2020) for EPS increase of Rs.107.23, since the company reported EPS of Rs.1.35; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted Negative EPS of Rs.105.88.

Disclaimer: Please note that the report submitted by the company is extremely difficult to read, hence there could be discrepancy in the figures or the amounts. And the report might not be accurate.

 


***All amounts are given in Million Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.